These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 33910128)

  • 21. In silico Screening for Identification of Novel Anti-malarial Inhibitors by Molecular Docking, Pharmacophore Modeling and Virtual Screening.
    Batool S; Khan ZA; Kamal W; Mushtaq G; Kamal MA
    Med Chem; 2015; 11(7):687-700. PubMed ID: 25741881
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Binding modes of reverse fosmidomycin analogs toward the antimalarial target IspC.
    Konzuch S; Umeda T; Held J; Hähn S; Brücher K; Lienau C; Behrendt CT; Gräwert T; Bacher A; Illarionov B; Fischer M; Mordmüller B; Tanaka N; Kurz T
    J Med Chem; 2014 Nov; 57(21):8827-38. PubMed ID: 25254502
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of Selective Novel Hits against
    Nyamai DW; Tastan Bishop Ö
    Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32471245
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MEPicides: potent antimalarial prodrugs targeting isoprenoid biosynthesis.
    Edwards RL; Brothers RC; Wang X; Maron MI; Ziniel PD; Tsang PS; Kraft TE; Hruz PW; Williamson KC; Dowd CS; John ARO
    Sci Rep; 2017 Aug; 7(1):8400. PubMed ID: 28827774
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative protein modeling of 1-deoxy-D-xylulose-5-phosphate reductoisomerase enzyme from Plasmodium falciparum: a potential target for antimalarial drug discovery.
    Singh N; Chevé G; Avery MA; McCurdy CR
    J Chem Inf Model; 2006; 46(3):1360-70. PubMed ID: 16711755
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A computational study of the molecular basis of antibiotic resistance in a DXR mutant.
    Krebs FS; Esque J; Stote RH
    J Comput Aided Mol Des; 2019 Oct; 33(10):927-940. PubMed ID: 31654265
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antimalarial and Structural Studies of Pyridine-containing Inhibitors of 1-Deoxyxylulose-5-phosphate Reductoisomerase.
    Xue J; Diao J; Cai G; Deng L; Zheng B; Yao Y; Song Y
    ACS Med Chem Lett; 2013 Feb; 4(2):278-282. PubMed ID: 23795240
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The non-mevalonate isoprenoid biosynthesis of plants as a test system for new herbicides and drugs against pathogenic bacteria and the malaria parasite.
    Lichtenthaler HK; Zeidler J; Schwender J; Müller C
    Z Naturforsch C J Biosci; 2000; 55(5-6):305-13. PubMed ID: 10928537
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel antiplasmodial compound: integration of
    Costa Júnior DB; Araújo JSC; Oliveira LM; Neri FSM; Moreira POL; Taranto AG; Fonseca AL; Varotti FP; Leite FHA
    J Biomol Struct Dyn; 2022 Sep; 40(14):6295-6307. PubMed ID: 33554762
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of new promising Plasmodium falciparum superoxide dismutase allosteric inhibitors through hierarchical pharmacophore-based virtual screening and molecular dynamics.
    Araujo JSC; de Souza BC; Costa Junior DB; Oliveira LM; Santana IB; Duarte AA; Lacerda PS; Dos Santos Junior MC; Leite FHA
    J Mol Model; 2018 Jul; 24(8):220. PubMed ID: 30056475
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular epidemiology of malaria in Cameroon. XXV. In vitro activity of fosmidomycin and its derivatives against fresh clinical isolates of Plasmodium falciparum and sequence analysis of 1-deoxy-D-xylulose 5-phosphate reductoisomerase.
    Tahar R; Basco LK
    Am J Trop Med Hyg; 2007 Aug; 77(2):214-20. PubMed ID: 17690389
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Towards new antimalarial drugs: synthesis of non-hydrolyzable phosphate mimics as feed for a predictive QSAR study on 1-deoxy-D-xylulose-5-phosphate reductoisomerase inhibitors.
    Giessmann D; Heidler P; Haemers T; Van Calenbergh S; Reichenberg A; Jomaa H; Weidemeyer C; Sanderbrand S; Wiesner J; Link A
    Chem Biodivers; 2008 Apr; 5(4):643-56. PubMed ID: 18421757
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacoinformatics based elucidation and designing of potential inhibitors against Plasmodium falciparum to target importin α/β mediated nuclear importation.
    Oany AR; Pervin T; Moni MA
    Infect Genet Evol; 2021 Mar; 88():104699. PubMed ID: 33385575
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The methylerythritol phosphate pathway is functionally active in all intraerythrocytic stages of Plasmodium falciparum.
    Cassera MB; Gozzo FC; D'Alexandri FL; Merino EF; del Portillo HA; Peres VJ; Almeida IC; Eberlin MN; Wunderlich G; Wiesner J; Jomaa H; Kimura EA; Katzin AM
    J Biol Chem; 2004 Dec; 279(50):51749-59. PubMed ID: 15452112
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional genetic analysis of the Plasmodium falciparum deoxyxylulose 5-phosphate reductoisomerase gene.
    Odom AR; Van Voorhis WC
    Mol Biochem Parasitol; 2010 Apr; 170(2):108-11. PubMed ID: 20018214
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exploring DOXP-reductoisomerase binding limits using phosphonated N-aryl and N-heteroarylcarboxamides as DXR inhibitors.
    Bodill T; Conibear AC; Mutorwa MK; Goble JL; Blatch GL; Lobb KA; Klein R; Kaye PT
    Bioorg Med Chem; 2013 Jul; 21(14):4332-41. PubMed ID: 23735832
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and anti-parasitic activity of N-benzylated phosphoramidate Mg
    Adeyemi CM; Hoppe HC; Isaacs M; Mnkandhla D; Lobb KA; Klein R; Kaye PT
    Bioorg Chem; 2020 Dec; 105():104280. PubMed ID: 33152647
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Double ester prodrugs of FR900098 display enhanced in-vitro antimalarial activity.
    Wiesner J; Ortmann R; Jomaa H; Schlitzer M
    Arch Pharm (Weinheim); 2007 Dec; 340(12):667-9. PubMed ID: 17994601
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fosmidomycin for the treatment of malaria.
    Wiesner J; Borrmann S; Jomaa H
    Parasitol Res; 2003 Jun; 90 Suppl 2():S71-6. PubMed ID: 12937969
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Screening and In Vitro Evaluation of Potential Plasmodium falciparum Leucyl Aminopeptidase Inhibitors.
    Chaudhary M; Singh V; Anvikar AR; Sahi S
    Curr Comput Aided Drug Des; 2016; 12(4):282-293. PubMed ID: 27449897
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.